LYRUS LIFE SCIENCES LIMITEDActive
Key figures
LYRUS LIFE SCIENCES LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024/25Balance sheet structure
Filed accounts2020/21–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Profit for the year | — | — | — | -105,543 | 24,165 |
| Cash at bank and in hand | 7,628 | 16,359 | 38,522 | 29,240 | 28,404 |
| Total assets | 343,777 | 465,471 | 799,864 | 895,344 | 1,066,288 |
| Total liabilities | 408,638 | 574,606 | 897,925 | 514,448 | 661,227 |
| Net assets / total equity | -64,861 | -109,135 | -98,061 | 380,896 | 405,061 |
| Average number of employees | 2 | 1 | 1 | 1 | 1 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activities continue to be of scientific and technical activities.
As described in the company's latest filed accounts.
Summary: LYRUS LIFE SCIENCES LIMITED
Company
LYRUS LIFE SCIENCES LIMITED is a private limited company registered with Companies House under company number 10436822. It was incorporated on 19 Oct 2016. Its status is active. The registered office is in Uxbridge (UB8). Its nature of business (SIC 2007) is other professional, scientific and technical activities n.e.c. (74909).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files small company accounts. Profit for the year was £24,165. Net assets were £405,061, up 6.3% on the previous year. Cash at bank and in hand was £28,404. Total assets were £1,066,288 and total liabilities £661,227. The company had an average of 1 employee. Figures are available for 5 financial years (2020/21–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 16 Feb 2027.